Conditions générales applicables au paiement par carte bancaire / Europe

Last update: 2024

 

These general terms and conditions (the "GTC") govern the contractual conditions applicable to the online payment of your invoices by credit card, without prejudice to the provisions of the content license agreement entered into between you and AFP.

By accepting these GTC online at the time of payment by credit card, you agree to abide by them.

For the purposes of these GTC, the terms :

 

General terms and conditions applicable to payment by credit card / North America

Last update: 2024

 

These general terms and conditions (the "GTC") govern the contractual conditions applicable to the online payment of your invoices by credit card, without prejudice to the provisions of the content license agreement entered into between you and AFP.

By accepting these GTC online at the time of payment by credit card, you agree to abide by them.

For the purposes of these GTC, the terms :

02/20/2025 12:01
The Future is Ambition Fuelled - Libertex Accelerates into Formula One as the Official Online Trading Partner of KICK Sauber F1 Team

Libertex, one of the leading online brokers, is proud to announce a groundbreaking multi-year partnership with KICK Sauber F1 Team, becoming the team's Official Online Trading Partner. This collaboration signifies a new era in Libertex’s dedication to performance, precision, and innovation, aligning seamlessly with the exhilarating world of Formula One as KICK Sauber F1 Team prepares to transition into the Audi F1 factory team from the 2026 season. This press release features multimedia. View t...

02/20/2025 12:00
Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round. Enki™ empowers biopharmaceutical chemistry teams to efficiently discover and optimize novel hits and leads, accelerating early-stage drug discovery. The round attracted strong investor interest, exceeding the company’s initial funding target, reflecting confidence in Enki’s potential. Nimbus Synergies ...